Zobrazeno 1 - 10
of 36
pro vyhledávání: '"V F, Tapson"'
Autor:
R James White, E Grünig, C Jerjes-Sanchez D, G M Bohns Meyer, T Pulido, P Sepulveda, K Y Wang, C Q Deng, R Grover, D Solum, A Ousmanou, V F Tapson
Publikováno v:
Pulmonary hypertension.
Background: Oral treprostinil (TRE) decreased the risk of adjudicated clinical worsening (CW) compared to placebo (PBO) in FREEDOM-EV (HR 0.74; 95% CI 0.56,0.97; p=0.0391). This prespecified analysis hypothesized that changes in NT-proBNP, World Heal
Autor:
Stephan Moll, E. Magnus Ohman, Tracy Y. Wang, Emily F. Honeycutt, Christopher B. Granger, V F Tapson
Publikováno v:
The American Journal of Medicine. 125:1214-1221
Background Heparin is commonly used for venous thromboembolism prophylaxis; however, the incidence of acquired thrombocytopenia in this setting has not been well described. Methods The Complications After Thrombocytopenia Caused by Heparin (CATCH) Re
Autor:
Robert D. Davis, L B Reller, Scott M. Palmer, V F Tapson, Linda L. Sanders, Lloyd J. Edwards, Barbara D. Alexander
Publikováno v:
Transplantation. 69:2360-2366
Background. Although infection is a leading cause of death after lung transplantation, very little is known about the incidence, epidemiology, and clinical significance of bloodstream infections in lung transplant recipients. Methods. All blood cultu
Autor:
H P McAdams, Nancy G. Henshaw, V F Tapson, Matar Ld, Robert D. Davis, Scott M. Palmer, David N. Howell
Publikováno v:
Radiology. 213:735-742
To evaluate radiologic finding of respiratory viral infection in lung transplant recipients with clinical correlation.Over 5 years, 21 episodes of respiratory viral infection (parainfluenza [n = 9], respiratory syncytial virus [n = 8], adenovirus [n
Autor:
V. F. Tapson, M.V. Huisman
Publikováno v:
European Respiratory Journal. 30:613-615
Antithrombotic treatment for acute deep vein thrombosis (DVT) or pulmonary embolism (PE) should consist of a therapeutic dose of low molecular weight heparin (LMWH) for ≥5 days, followed by a vitamin K antagonist for ≥3 months. LMWH has simplifie
Autor:
V. F. Tapson, E. H. Nichols
Publikováno v:
MD Conference Express. 14:24-25
Publikováno v:
Chest. 112:435-439
Lung transplantation has become a therapeutic option for end-stage pulmonary diseases, but after transplantation, infections and obliterative bronchiolitis (OB) are major causes of long-term morbidity and mortality. OB is a fibroproliferative disease
Autor:
R J, Barst, L J, Rubin, W A, Long, M D, McGoon, S, Rich, D B, Badesch, B M, Groves, V F, Tapson, R C, Bourge, B H, Brundage, S K, Koerner, D, Langleben, C A, Keller, S, Murali, B F, Uretsky, L M, Clayton, M M, Jöbsis, S D, Blackburn, D, Shortino, J W, Crow, A, Krichman
Publikováno v:
New England Journal of Medicine. 334:296-301
Primary pulmonary hypertension is a progressive disease for which no treatment has been shown in a prospective, randomized trial to improve survival.We conducted a 12-week prospective, randomized, multicenter open trial comparing the effects of the c
Publikováno v:
American Journal of Respiratory and Critical Care Medicine. 151:895-898
Diffuse panbronchiolitis (DBP) is characterized by chronic inflammation of the upper and lower respiratory tract. DPB has been found almost exclusively in oriental populations. We describe the occurrence of a case of DPB in an African American patien
Publikováno v:
American Journal of Respiratory and Critical Care Medicine. 151:895-898